Put hope in sight and help our researchers make breakthroughs and innovations that will transform our understanding and treatment of age-related macular degeneration.
Your donation will support world-first research and clinical trials that will advance our understanding of vision loss.
A world-leading multidisciplinary research project, investigating age-related macular degeneration and the factors that make some people more likely to lose their vision.
In this video, learn about CERA’s research into gene therapies that could halt or even reverse vision loss in patients with conditions such as inherited retinal diseases and glaucoma.
Australia’s first clinical trials of an investigational gene therapy to treat dry age-related macular degeneration (AMD) have begun at the Centre for Eye Research Australia (CERA).
Scientists have used a new gene therapy technique to repair damage to nerve cell transport systems that cause vision loss in glaucoma and memory loss in dementia.
